EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

The Neural Signature of Impaired Inhibitory Control in Individuals with Heroin Use Disorder

Ahmet O Ceceli iD, Sarah G King, Natalie McClain, Nelly Alia-Klein, Rita Z Goldstein

The Journal of Neuroscience · 04.01.2023 · 43 (1) · 173-182

DOI: 10.1523/jneurosci.1237-22.2022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Neuroscience, online erschienen am 17.11.2022. Verfasst von Ahmet O Ceceli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York 10029. Hauptthemen laut MEDLINE: Heroin Dependence, Behavior, Addictive. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: NCCIH NIH HHS, NIDA NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heroin addiction imposes a devastating toll on society, with little known about its neurobiology. Excessive salience attribution to drug over nondrug cues/reinforcers, with concomitant inhibitory control decreases, are common mechanisms underlying drug addiction. Although inhibitory control alterations generally culminate in prefrontal cortex (PFC) hypoactivations across drugs of abuse, patterns in individuals with heroin addiction (iHUDs) remain unknown. We used a stop-signal fMRI task designed to meet recent consensus guidelines in mapping inhibitory control in 41 iHUDs and 24 age- and sex-matched healthy controls (HCs). Despite group similarities in the stop-signal response time (SSRT; the classic inhibitory control measure), compared with HCs, iHUDs exhibited impaired target detection sensitivity (proportion of hits in go vs false alarms in stop trials; p = 0.003). Additionally, iHUDs exhibited lower right anterior PFC (aPFC) and dorsolateral PFC (dlPFC) activity during successful versus failed stops (the hallmark inhibitory control contrast). Lower left dlPFC/supplementary motor area (SMA) activity was associated with slower SSRT specifically in iHUDs and lower left aPFC activity with worse target sensitivity across all participants ( p < 0.05 corrected). Importantly, in iHUDs, lower left SMA and aPFC activity during inhibitory control was associated with shorter time since last use and higher severity of dependence, respectively ( p < 0.05 corrected). Together, results revealed lower perceptual sensitivity and hypoactivations during inhibitory control in cognitive control regions (e.g., aPFC, dlPFC, SMA) as associated with task performance and heroin use severity measures in iHUDs. Such neurobehavioral inhibitory control deficits may contribute to self-control lapses in heroin addiction, constituting targets for prevention and intervention efforts to enhance recovery. SIGNIFICANCE STATEMENT Heroin addiction continues its deadly impact, with little known about the neurobiology of this disorder. Although behavioral and prefrontal cortical impairments in inhibitory control characterize addiction across drugs of abuse, these patterns remain underexplored in heroin addiction. Here, we illustrate a significant behavioral impairment in target discrimination in individuals with heroin addiction compared with matched healthy controls. We further show lower engagement during inhibitory control in the anterior and dorsolateral prefrontal cortex (key regions that regulate cognitive control) as associated with slower stopping, worse discrimination, and heroin use measures. Mapping the neurobiology of inhibitory control in heroin addiction for the first time, we identify potential treatment targets inclusive of prefrontal cortex-mediated cognitive control amenable for neuromodulation en route to recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heroin DependenceBehavior, AddictiveHumansHeroinPrefrontal CortexReaction TimeMagnetic Resonance Imaging

Stichwörter der Autor:innen

cognitive controlopiateprefrontal cortexresponse inhibitionstop-signal tasksubstance use disorder

Substanzen

Heroin

Autor:innen und Institutionen

  • Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
  • Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
  • Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York 10029 rita.goldstein@mssm.edu.

ORCID-Profile: Ahmet O Ceceli

Förderung

  • NCCIH NIH HHS
  • NIDA NIH HHS
  • NCATS NIH HHS
  • HHS | NIH | National Center for Complementary and Integrative Health

Zitieren

APA

Ceceli, A. O., King, S. G., McClain, N., Alia-Klein, N., & Goldstein, R. Z. (2023). The Neural Signature of Impaired Inhibitory Control in Individuals with Heroin Use Disorder. The Journal of Neuroscience, 43(1), 173-182. https://doi.org/10.1523/jneurosci.1237-22.2022

Vancouver

Ceceli AO, King SG, McClain N, Alia-Klein N, Goldstein RZ. The Neural Signature of Impaired Inhibitory Control in Individuals with Heroin Use Disorder. The Journal of Neuroscience. 2023;43(1):173-182. doi:10.1523/jneurosci.1237-22.2022

BibTeX
@article{Ceceli2023,
  author = {Ceceli, Ahmet O and King, Sarah G and McClain, Natalie and Alia-Klein, Nelly and Goldstein, Rita Z},
  title = {The Neural Signature of Impaired Inhibitory Control in Individuals with Heroin Use Disorder},
  journal = {The Journal of Neuroscience},
  year = {2023},
  volume = {43},
  number = {1},
  pages = {173--182},
  doi = {10.1523/jneurosci.1237-22.2022}
}
Kostenlos starten →